WallStreetZen

NYSE: ABBV
AbbVie Inc Stock

$115.91+0.63 (+0.55%)
Updated Dec 1, 2021
ABBV Price
$115.91
Fair Value Price
N/A
Market Cap
$202.97B
52 Week Low
$101.55
52 Week High
$121.53
P/E
27.93x
P/B
14.98x
P/S
3.46x
PEG
0.62x
Dividend Yield
4.49%
Revenue
$55.17B
Earnings
$7.53B
Gross Margin
67.7%
Operating Margin
17.46%
Profit Margin
13.7%
Debt to Equity
9.98
Operating Cash Flow
$23B
Beta
0.79
Next Earnings
Feb 1, 2022
Ex-Dividend
Jan 13, 2022
Next Dividend
Feb 15, 2022

Zen Score

High
Medium
Low
47
Industry average

Reasons for this score

ABBV ($115.91) is trading below its intrinsic value of $646.23, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
ABBV is good value based on its earnings relative to its share price (27.93x), compared to the US market average 38.14x)
Valuation
ABBV is poor value based on its earnings relative to its share price (27.93x), compared to the US Drug Manufacturers - General industry average (24.84x)
Valuation

1 of 12

ABBV News

Valuation

ABBV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
27.93x
Industry
24.84x
Market
38.14x
ABBV is good value based on its earnings relative to its share price (27.93x), compared to the US market average 38.14x)
Valuation
ABBV is poor value based on its earnings relative to its share price (27.93x), compared to the US Drug Manufacturers - General industry average (24.84x)
Valuation

ABBV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
14.98x
Industry
4.91x
ABBV is poor value based on its book value relative to its share price (14.98x), compared to the US Drug Manufacturers - General industry average (4.91x)
Valuation

ABBV price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABBV is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.62x)
Valuation

ABBV's financial health

Profit margin

Revenue
$14.3B
Net Income
$3.2B
Profit Margin
22.2%
ABBV's Earnings (EBIT) of $9.63B are insufficient to safely cover interest payments on company debt ($80.72B)
Financials
ABBV's profit margin has decreased (-4.5%) in the last year from (18.2%) to (13.7%)
Financials

Assets to liabilities

Assets
$148.9B
Liabilities
$135.3B
Debt to equity
5.96
ABBV's short-term assets ($28.96B) exceed its short-term liabilities ($28.53B)
Financials
ABBV's long-term liabilities ($106.75B) exceed its short-term assets ($28.96B)
Financials
ABBV's debt has increased relative to shareholder equity (9.98), over the past 5 years ago (9.3)
Financials
ABBV's debt to equity ratio (9.98) is considered high
Financials

Cash flow

Operating
$7.9B
Investing
-$615.0M
Financing
-$3.6B
ABBV's operating cash flow ($22.56B) is sufficient to service the company's debt ($80.72B)
Financials

AbbVie Stock FAQ

What is AbbVie's quote symbol?

(NYSE: ABBV) AbbVie trades on the NYSE under the ticker symbol ABBV. AbbVie stock quotes can also be displayed as NYSE: ABBV.

What is the 52 week high and low for AbbVie (NYSE: ABBV)?

(NYSE: ABBV) AbbVie's 52-week high was $121.53, and its 52-week low was $101.55. It is currently -4.62% from its 52-week high and 14.14% from its 52-week low.

How much is AbbVie stock worth today?

(NYSE: ABBV) AbbVie currently has 1,767,880,465 outstanding shares. With AbbVie stock trading at $115.91 per share, the total value of AbbVie stock (market capitalization) is $202.97B.

AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. If you had invested in AbbVie stock at $35.12, your return over the last 8 years would have been 230.04%, for an annualized return of 16.1% (not including any dividends or dividend reinvestments).

How much is AbbVie's stock price per share?

(NYSE: ABBV) AbbVie stock price per share is $115.91 today (as of Dec 1, 2021).

What is AbbVie's Market Cap?

(NYSE: ABBV) AbbVie's market cap is $202.97B, as of Dec 2, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

AbbVie's market cap is calculated by multiplying ABBV's current stock price of $115.91 by ABBV's total outstanding shares of 1,767,880,465.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.